Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa.
View / Open Files
Authors
Ahuno, Samuel Terkper
Ahearn, Thomas U
Yarney, Joel
Titiloye, Nicholas
Hamel, Nancy
Adjei, Ernest
Clegg-Lamptey, Joe-Nat
Edusei, Lawrence
Awuah, Baffour
Song, Xiaoyu
Vanderpuye, Verna
Stover, Daniel G
Nyarko, Kofi
Ansong, Daniel
Gardner, Kevin L
Boateng, Felix Andy
Bowcock, Anne M
Wiafe-Addai, Beatrice
Garcia-Closas, Montserrat
Kwarteng, Alexander
Ghana Breast Health Study Team
Publication Date
2021-09-17Journal Title
NPJ Precis Oncol
ISSN
2397-768X
Publisher
Springer Science and Business Media LLC
Volume
5
Issue
1
Pages
83
Language
eng
Type
Article
This Version
VoR
Physical Medium
Electronic
Metadata
Show full item recordCitation
Ahuno, S. T., Doebley, A., Ahearn, T. U., Yarney, J., Titiloye, N., Hamel, N., Adjei, E., et al. (2021). Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa.. NPJ Precis Oncol, 5 (1), 83. https://doi.org/10.1038/s41698-021-00219-7
Abstract
Circulating tumor DNA (ctDNA) sequencing studies could provide novel insights into the molecular pathology of cancer in sub-Saharan Africa. In 15 patient plasma samples collected at the time of diagnosis as part of the Ghana Breast Health Study and unselected for tumor grade and subtype, ctDNA was detected in a majority of patients based on whole- genome sequencing at high (30×) and low (0.1×) depths. Breast cancer driver copy number alterations were observed in the majority of patients.
Keywords
Ghana Breast Health Study Team
Identifiers
External DOI: https://doi.org/10.1038/s41698-021-00219-7
This record's URL: https://www.repository.cam.ac.uk/handle/1810/329638
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk